Exagen (NASDAQ:XGN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Exagen (XGN) operate in?

Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Exagen Stock (NASDAQ: XGN) stock price, news, charts, stock research, profile.

Open	$1.76
Close	$1.81
Volume / Avg.	7.43K / 36.24K
Day Range	1.75 - 1.81
52 Wk Range	1.30 - 3.04
Market Cap	$31.79M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	0.19%
Days to Cover	1

Recent News

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.

Zacks

Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday

With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Exagen Inc

Sector

Health Care

Industry

Biotechnology

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Exagen (XGN) stock?

You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.

View our list of the best stock brokerages

Who are Exagen (XGN) competitors?

Other companies in Exagen’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX) and Immuneering (NASDAQ:IMRX).

What is the target price for Exagen (XGN) stock?

There is no analysis for Exagen.

What is the forecast for Exagen (XGN) stock?

Exagen has a consensus price target of $9.00.

Current stock price for Exagen (XGN)?

The stock price for Exagen (NASDAQ: XGN) is $1.83 last updated July 3, 2024 at 2:19 PM EDT.

Does Exagen (XGN) pay a dividend?

There are no upcoming dividends for Exagen.

When is Exagen (NASDAQ:XGN) reporting earnings?

Exagen’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is Exagen (XGN) going to split?

There is no upcoming split for Exagen.

What sector and industry does Exagen (XGN) operate in?

Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Exagen

Exagen (XGN) Forecast